VIPVIZA - VIsualiZation of asymptomatic Atherosclerotic disease for optimum cardiovascular prevention ─ a randomized controlled trial nested in the Västerbotten Intervention Program
SND-ID: 2020-204-1.
Associated documentation
Alternative title
VIPVIZA
Creator/Principal investigator(s)
Margareta Norberg - Umeå University, Department of Epidemiology and Global Health
Ulf Näslund - Umeå University, Public Health and Clinical Medicine
Patrik Wennberg - Umeå University, Family Medicine
Umeå University, Department of Public Health and Clinical Medicine
Research principal
Umeå University - Department of Public Health and Clinical Medicine
Description
The aim of the project is to develop better methods for prevention of cardiovascular diseases (CVD). It is based on the hypothesis that image-based information on subclinical atherosclerosis (i) increases the precision in the assessment of risk of CVD, (ii) improves communication and understanding of the risk, and as a consequence (iii) the motivation for and adherence to evidence-based pharmacological treatment and lifestyle modification will increase. In addition to conventional risk factor assessment and CVD prevention within the framework of Västerbotten Intervention Program.
3500 healthy participants with low/moderate risk of CVD underwent ultrasound examination of the carotid arteries and were randomized to two groups. In the intervention group, the participants and their doctors received pictorial and graphic information in color about the participant’s subclinical atherosclerosis. No information about the ultrasound results was given to the control group. Follow-up after 1, 3 and 6.5 years includes sampling regarding clinical risk factors, blood for biomarker analyses, extensive quest
3500 healthy participants with low/moderate risk of CVD underwent ultrasound examination of the carotid arteries and were randomized to two groups. In the intervention group, the participants and their doctors received pictorial and graphic information in color about the participant’s subclinical atherosclerosis. No information about the ultrasound results was given to the control group. Follow-up after 1, 3 and 6.5 years includes sampling regarding clinical risk factors, blood for biomarker analyses, extensive questionnaires and interviews.
At 3 and 6.5 years the ultrasound examination was repeated and all participants and their doctors were informed about the results. The database also includes register data regarding prescriptions of preventive medication, exposure data for air pollutants, data from health examinations within the VIP 10 and 20 years before VIPVIZA, and for men conscription data.
After 10 years, registry data on endpoints, CVD morbidity and mortality will be collected.
Access to VIPVIZA's data portal and research data from VIPVIZA is possible in collaboration with researchers within the VIPVIZA project. For further information, contact PI Ulf Näslund ulf.naslund@umu.se Show less..
Data contains personal data
Yes
Sensitive personal data
Yes
Type of personal data
Medical data at individual level
Code key exists
Yes
Language
Unit of analysis
Population
Healthy subjects aged 40-60 years at low/moderate risk of cardiovascular disease
Study design
Randomised controlled trial (RCT)
Description of study design
Pagmatic open-label, randomised controlled trial with masked evaluators (PROBE)
Sampling procedure
Exclusion criterion: More than 50% narrowing of the lumen of carotid areteries
Time period(s) investigated
2013 – Ongoing
Biobank is connected to the study
Yes
Number of individuals/objects
3532
Data format / data structure
Geographic spread
Geographic location: Västerbotten County
Geographic description: Region Västerbotten
Highest geographic unit
Region
Responsible department/unit
Department of Public Health and Clinical Medicine
Contributor(s)
Wolfgang Lohr - Umeå University, Department of Epidemiology and Global HEalth
Ethics Review
Swedish Ethical Review Authority - Ref. Dnr 2011-441-31M. Amendments:Dnr 2012-463-32M, Dnr 2013-373-32M, Dnr 2016-245-32M, Dnr 2017-95-32M, Dnr 2018-182-32, Dnr 2018-482-32M, Dnr 2019-0691, Dnr Ö 23-2020/3.1
Research area
Cardiac and cardiovascular systems (Standard för svensk indelning av forskningsämnen 2011)
Radiology, nuclear medicine and medical imaging (Standard för svensk indelning av forskningsämnen 2011)
Clinical laboratory medicine (Standard för svensk indelning av forskningsämnen 2011)
General practice (Standard för svensk indelning av forskningsämnen 2011)
Public health, global health, social medicine and epidemiology (Standard för svensk indelning av forskningsämnen 2011)
Medical biotechnology (focus on cell biology (incl. stem cell biology), molecular biology, microbiology, biochemistry or biopharmacy) (Standard för svensk indelning av forskningsämnen 2011)
Psychology (Standard för svensk indelning av forskningsämnen 2011)
Keywords
Vanoli, D. (2017). Vascular ultrasound for the assessment of carotid atherosclerosis [PhD dissertation, Umeå University]. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-139538
ISBN:
978-91-7601-748-7
URN:
urn:nbn:se:umu:diva-139538
Vanoli, D., Lindqvist, P., Wiklund, U., Henein, M., & Näslund, U. (2013). Fully automated on-screen carotid intima-media thickness measurement : a screening tool for subclinical atherosclerosis. Journal of Clinical Ultrasound, 41(6), 333–339. https://doi.org/10.1002/jcu.22041
URN:
urn:nbn:se:umu:diva-78429
DOI:
https://doi.org/10.1002/jcu.22041
Vanoli, D., Wiklund, U., Lindqvist, P., Henein, M., & Näslund, U. (2014). Successful novice’s training in obtaining accurate assessment of carotid IMT using an automated ultrasound system. European Heart Journal Cardiovascular Imaging, 15(6), 637–642. https://doi.org/10.1093/ehjci/jet254
DOI:
https://doi.org/10.1093/ehjci/jet254
URN:
urn:nbn:se:umu:diva-91057
Lindahl, B., Norberg, M., Johansson, H., Lindvall, K., Ng, N., Nordin, M., Nordin, S., Näslund, U., Persson, A., Vanoli, D., & Schulz, P. J. (2020). Health literacy is independently and inversely associated with carotid artery plaques and cardiovascular risk. European Journal of Preventive Cardiology, 27(2), 209–215. https://doi.org/10.1177/2047487319882821
DOI:
https://doi.org/10.1177/2047487319882821
URN:
urn:nbn:se:umu:diva-165791
Nyman, E., Vanoli, D., Näslund, U., & Grönlund, C. (2020). Inter-sonographer reproducibility of carotid ultrasound plaque detection using Mannheim consensus in subclinical atherosclerosis. Clinical Physiology and Functional Imaging, 40(1), 46–51. https://doi.org/10.1111/cpf.12602
DOI:
https://doi.org/10.1111/cpf.12602
URN:
urn:nbn:se:umu:diva-165443
Näslund, U., Ng, N., Lundgren, A., Fhärm, E., Grönlund, C., Johansson, H., Lindahl, B., Lindahl, B., Lindvall, K., Nilsson, S. K., Nordin, M., Nordin, S., Nyman, E., Rocklöv, J., Vanoli, D., Weinehall, L., Wennberg, P., Wester, P., & Norberg, M. (2019). Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA) : a pragmatic, open-label, randomised controlled trial. The Lancet, 393(10167), 133–142. https://doi.org/10.1016/S0140-6736(18)32818-6
DOI:
https://doi.org/10.1016/S0140-6736(18)32818-6
URN:
urn:nbn:se:umu:diva-154318
Nyman, E., Lindqvist, P., Näslund, U., & Grönlund, C. (2018). Risk marker variability in subclinical carotid plaques based on ultrasound is influenced by cardiac phase, echogenicity and size. In Ultrasound in Medicine and Biology (Vol. 44, Issue 8, pp. 1742–1750). https://doi.org/10.1016/j.ultrasmedbio.2018.03.013
DOI:
https://doi.org/10.1016/j.ultrasmedbio.2018.03.013
URN:
urn:nbn:se:umu:diva-150664
SwePub:
oai:DiVA.org:umu-150664
Sjölander, M., Carlberg, B., Norberg, M., Näslund, U., & Ng, N. (n.d.). Prescription of Lipid-Lowering and Antihypertensive Drugs Following Pictorial Information About Subclinical Atherosclerosis A Secondary Outcome of a Randomized Clinical Trial. JAMA Netw Open. 2021;4(8):e2121683. https://doi.org/10.1001/jamanetworkopen.2021.21683
DOI:
https://doi.org/10.1001/jamanetworkopen.2021.21683
URN:
urn:nbn:se:umu:diva-187088
SwePub:
oai:gup.ub.gu.se/307669
Bengtsson, A., Lindvall, K., Norberg, M., & Fhärm, E. (2021). Increased knowledge makes a difference!–general practitioners’ experiences of pictorial information about subclinical atherosclerosis for primary prevention: an interview study from the VIPVIZA trial. Scandinavian Journal of Primary Health Care, 39(1), 77-84. https://doi.org/10.1080/02813432.2021.1882083
URN:
urn:nbn:se:umu:diva-181026
DOI:
https://doi.org/10.1080/02813432.2021.1882083
SwePub:
oai:DiVA.org:umu-181026
Rohlén, R., Jiang, B., Nyman, E., Wester, P., Näslund, U. and Grönlund, C. (2023), Interframe Echo Intensity Variation of Subregions and Whole Plaque in Two-Dimensional Carotid Ultrasonography. J Ultrasound Med, 42: 1033-1046. https://doi.org/10.1002/jum.16114
URN:
urn:nbn:se:umu:diva-200460
DOI:
https://doi.org/10.1002/jum.16114
SwePub:
oai:DiVA.org:umu-200460
Nilsson Sommar, J., Norberg, M., Grönlund, C., Segersson, D., Näslund, U., & Forsberg, B. (2022). Long-term exposure to particulate air pollution and presence and progression of carotid artery plaques : A northern Sweden VIPVIZA cohort study. In Environmental Research (No. 113061; Vol. 211). https://doi.org/10.1016/j.envres.2022.113061
URN:
urn:nbn:se:umu:diva-192989
DOI:
https://doi.org/10.1016/j.envres.2022.113061
SwePub:
oai:DiVA.org:umu-192989
Bengtsson, A., Norberg, M., Ng, N., Carlberg, B., Grönlund, C., Hultdin, J., Lindahl, B., Lindahl, B., Nordin, S., Nyman, E., Wennberg, P., Wester, P., & Näslund, U. (2021). The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk : results from the VIPVIZA randomized clinical trial. In American Journal of Preventive Cardiology (No. 100199; Vol. 7). https://doi.org/10.1016/j.ajpc.2021.100199
URN:
urn:nbn:se:umu:diva-186686
DOI:
https://doi.org/10.1016/j.ajpc.2021.100199
SwePub:
oai:DiVA.org:umu-186686
Holmberg, H., Sjölander, M., Glader, E.-L., Näslund, U., Carlberg, B., Norberg, M., & Själander, A. (2022). Time to initiation of lipid-lowering drugs for subclinical atherosclerosis : sub-study of VIPVIZA randomized controlled trial, with single-arm cross-over. In European Heart Journal Open (No. oeac003; Vol. 2, Issue 1). https://doi.org/10.1093/ehjopen/oeac003
DOI:
https://doi.org/10.1093/ehjopen/oeac003
URN:
urn:nbn:se:umu:diva-201549
SwePub:
oai:DiVA.org:umu-201549
Kovrov, O., Landfors, F., Saar-Kovrov, V., Näslund, U., & Olivecrona, G. (2022). Lipoprotein size is a main determinant for the rate of hydrolysis by exogenous LPL in human plasma. In Journal of Lipid Research (No. 100144; Vol. 63, Issue 1). https://doi.org/10.1016/j.jlr.2021.100144
URN:
urn:nbn:se:umu:diva-191885
DOI:
https://doi.org/10.1016/j.jlr.2021.100144
SwePub:
oai:DiVA.org:umu-191885
Schulz, P. J., Lindahl, B., Hartung, U., Näslund, U., Norberg, M., & Nordin, S. (2022). The right pick : Does a self-assessment measurement tool correctly identify health care consumers with inadequate health literacy? In Patient Education and Counseling (Vol. 105, Issue 4, pp. 926–932). https://doi.org/10.1016/j.pec.2021.07.045
URN:
urn:nbn:se:umu:diva-186967
DOI:
https://doi.org/10.1016/j.pec.2021.07.045
SwePub:
oai:DiVA.org:umu-186967
Andersson, E. M., Liv, P., Nordin, S., Näslund, U., & Lindvall, K. (2024). Does a multi-component intervention including pictorial risk communication about subclinical atherosclerosis improve perceptions of cardiovascular disease risk without deteriorating efficacy beliefs? In Social Science and Medicine (No. 116530; Vol. 341). https://doi.org/10.1016/j.socscimed.2023.116530
URN:
urn:nbn:se:umu:diva-218586
DOI:
https://doi.org/10.1016/j.socscimed.2023.116530
SwePub:
oai:DiVA.org:umu-218586
Salvador, D., Liv, P., Norberg, M., Pahud de Mortanges, A., Saner, H., Glisic, M., Nicoll, R., Muka, T., Nyman, E., Bano, A., & Näslund, U. (2023). Changes in fasting plasma glucose and subclinical atherosclerosis : a cohort study from VIPVIZA trial. In Atherosclerosis. https://doi.org/10.1016/j.atherosclerosis.2023.117326
DOI:
https://doi.org/10.1016/j.atherosclerosis.2023.117326
URN:
urn:nbn:se:umu:diva-216637
SwePub:
oai:DiVA.org:umu-216637
Nordin, S., Norberg, M., Braf, I., Johansson, H., Lindahl, B., Lindvall, K., Nordin, M., Nyman, E., Vallström, C., Wennberg, P., Liv, P., & Näslund, U. (2023). Associations between emotional support and cardiovascular risk factors and subclinical atherosclerosis in middle-age. In Psychology and Health. https://doi.org/10.1080/08870446.2023.2286296
DOI:
https://doi.org/10.1080/08870446.2023.2286296
URN:
urn:nbn:se:umu:diva-217344
SwePub:
oai:DiVA.org:umu-217344
Bengtsson, A., Nyman, E., Grönlund, C., Wester, P., Näslund, U., Fhärm, E., & Norberg, M. (2023). Multi-view carotid ultrasound is stronger associated with cardiovascular risk factors than presence of plaque or single carotid intima media thickness measurements in subclinical atherosclerosis. In The International Journal of Cardiovascular Imaging (Vol. 39, Issue 8, pp. 1461–1471). https://doi.org/10.1007/s10554-023-02868-0
DOI:
https://doi.org/10.1007/s10554-023-02868-0
URN:
urn:nbn:se:umu:diva-209575
SwePub:
oai:DiVA.org:umu-209575
Ali, H., Nyman, E., Näslund, U., & Grönlund, C. (2023). Translation of atherosclerotic disease features onto healthy carotid ultrasound images using domain-to-domain translation. In Biomedical Signal Processing and Control (No. 104886; Vol. 85). https://doi.org/10.1016/j.bspc.2023.104886
URN:
urn:nbn:se:umu:diva-206526
DOI:
https://doi.org/10.1016/j.bspc.2023.104886
SwePub:
oai:DiVA.org:umu-206526
Fortuin-de Smidt, M., Bergman, F., Grönlund, C., Hult, A., Norberg, M., Wennberg, M., & Wennberg, P. (2023). Early adulthood exercise capacity, but not muscle strength, associates with subclinical atherosclerosis 40 years later in Swedish men. In European Journal of Preventive Cardiology (Vol. 30, Issue 5, pp. 407–415). https://doi.org/10.1093/eurjpc/zwad007
URN:
urn:nbn:se:umu:diva-206445
DOI:
https://doi.org/10.1093/eurjpc/zwad007
SwePub:
oai:DiVA.org:umu-206445
Andersson, E. M., Johansson, H., Nordin, S., & Lindvall, K. (2022). Cognitive and emotional reactions to pictorial-based risk communication on subclinical atherosclerosis : a qualitative study within the VIPVIZA trial. In Scandinavian Journal of Primary Health Care (Vol. 41, Issue 1, pp. 69–80). https://doi.org/10.1080/02813432.2023.2178850
URN:
urn:nbn:se:umu:diva-205734
DOI:
https://doi.org/10.1080/02813432.2023.2178850
SwePub:
oai:DiVA.org:umu-205734
Nyman, E., Grönlund, C., Vanoli, D., Liv, P., Norberg, M., Bengtsson, A., Wennberg, P., Wester, P., & Näslund, U. (2023). Reduced progression of carotid intima media thickness by personalised pictorial presentation of subclinical atherosclerosis in VIPVIZA : A randomised controlled trial. In Clinical Physiology and Functional Imaging (Vol. 43, Issue 4, pp. 232–241). https://doi.org/10.1111/cpf.12811
DOI:
https://doi.org/10.1111/cpf.12811
URN:
urn:nbn:se:umu:diva-204766
SwePub:
oai:DiVA.org:umu-204766
Nyman, E., Liv, P., Wester, P., Näslund, U., & Grönlund, C. (2023). Carotid wall echogenicity at baseline associates with accelerated vascular aging in a middle-aged population. In The International Journal of Cardiovascular Imaging (Vol. 39, Issue 3, pp. 575–583). https://doi.org/10.1007/s10554-022-02760-3
URN:
urn:nbn:se:umu:diva-204476
DOI:
https://doi.org/10.1007/s10554-022-02760-3
SwePub:
oai:DiVA.org:umu-204476
Andersson, E. M., Lindvall, K., Wennberg, P., Johansson, H., & Nordin, S. (2024). From risk communication about asymptomatic atherosclerosis to cognitive and emotional reactions and lifestyle modification. In BMC Psychology (No. 47; Vol. 12, Issue 1). https://doi.org/10.1186/s40359-023-01467-x
URN:
urn:nbn:se:umu:diva-218585
DOI:
https://doi.org/10.1186/s40359-023-01467-x
SwePub:
oai:DiVA.org:umu-218585
If you have published anything based on these data, please notify us with a reference to your publication(s). If you are responsible for the catalogue entry, you can update the metadata/data description in DORIS.